Yttrium-90 (90Y) ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-Cell non-Hodgkin's lymphoma (Q81711726)
Jump to navigation
Jump to search
scientific article published on 01 April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Yttrium-90 (90Y) ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-Cell non-Hodgkin's lymphoma |
scientific article published on 01 April 2005 |
Statements
Yttrium-90 (90Y) ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-Cell non-Hodgkin's lymphoma (English)
Gregory A Wiseman